Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003472455 | SCV004202218 | likely pathogenic | Polycystic kidney disease 4 | 2023-10-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003611653 | SCV004424867 | pathogenic | Autosomal recessive polycystic kidney disease | 2023-03-19 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with PKHD1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Trp1934Glyfs*40) in the PKHD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PKHD1 are known to be pathogenic (PMID: 19940839). |